Home Administrative Billing & Reimbursement Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Upcoming precertification requirement changes for most commercial AmeriHealth New Jersey members

May 31, 2012

[

We previously communicated that the changes detailed below would be made to the list of services and drugs that require precertification for most commercial AmeriHealth New Jersey members effective for dates of service on or after June 1, 2012.* Please note that these changes will now go into effect for dates of service on or after July 1, 2012.

The following precertification requirements are being added in all settings effective for dates of service on or after July 1, 2012:

  • potentially cosmetic procedures (please refer to the complete list below);
  • pain management procedures (paravertebral facet joint injections, transforaminal epidural injections, epidural injections);
  • additional medical infusion/injectable drugs (please refer to the complete list below);
  • cataract surgery;
  • cochlear implant surgery;
  • hyperbaric oxygen;
  • uvulopalatopharyngoplasty (UPPP or UP3).

The following precertification requirements are being removed in all settings effective for dates of service on or after July 1, 2012:

  • sleep studies
  • cardiac rehabilitation
  • pulmonary rehabilitation

Cardiac radiology services

We also communicated that we will require precertification for cardiac radiology services (stress echocardiography, resting transthoracic echocardiography, and transesophageal echocardiography) for most commercial AmeriHealth New Jersey members effective for dates of service on or after June 1, 2012.*

Please note that we will allow a 30-day grace period for enforcement of these new precertification requirements, and providers will be required to observe these updated precertification requirements for dates of service on or after July 1, 2012. However, providers can begin to submit precertification requests for these services as of June 1, 2012.

It is very important that providers verify member-specific requirements using the NaviNet? web portal or by referring to the most current precertification requirement lists on our website. Failure to obtain precertification for any of the services or drugs that require it for dates of service on or after July 1, 2012, may result in a reduction in payment or nonpayment for the services not precertified.

Please call Customer Service at 1-800-275-2583 if you have any questions about these changes to precertification requirements.

Potentially cosmetic procedures that will require precertification

Blepharoplasty/ptsosis repair

Hair transplant

Rhinoplasty

Breast: reconstruction, reduction, augmentation, mammoplasty, mastopexy, insertion, and removal of breast implants

Injectable dermal fillers

Rhytidectomy

Canthopexy/canthoplasty

Keloid removal

Scar revision

Cervicoplasty

Labiaplasty

Sex reassignment surgery

Chemical peels

Lipectomy, liposuction, or any other excess fat removal procedure

Skin closures including: skin grafts, skin flaps, and tissue grafts

Dermabrasion

Orthognathic surgery procedures including, but not limited to: bone graft, genioplasty, osteoplasty, mentoplasty, osteotomies

Surgery for varicose veins, including perforators and sclerotherapy

Excision of excessive skin and/or subcutaneous tissue

Otoplasty

Surgical treatment of gynecomastia

Genetically and bio-engineered skin substitutes for wound care


Additional infusion drugs that will require precertification

Abraxane?

Flolan?

Jevtana?

Alimta?

Folotyn?

Nulojix?

Alpha 1 inhibitors (Aralast NPTM, GlassiaTM, Prolastin? C, Zemaira?)

Gammaplex? (IVIG)

Provenge?

ArzerraTM

HalavenTM

Psoriasis/rheumatoid arthritis (Actemra?)

Benlysta?

Hemophilia factors

Remodulin?

C1 esterase inhibitors (Berinert?, Cinryze?)

Herceptin? DM1*

Soliris?

Enzyme replacement (ElelysoTM, Lumizyme?, Replagal?**, VPRIV?)

Istodax?

YervoyTM


Additional injectable drugs that will require precertification

Kalbitor?

MakenaTM

Stelara?

Lucentis?

OmaproTM*

XgevaTM

Macugen?

Prolia?

Xolair?

*Comprehensive Major Medical [CMM] members are excluded. This change is pending approval from the New Jersey Department of Banking and Insurance for Small Employer Health (SEH) members.

**This drug is pending approval from the U.S. Food and Drug Administration.

NaviNet® is a registered trademark of NaviNet, Inc.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of AmeriHealth, AmeriHealth HMO, Inc., AmeriHealth Insurance Company of New Jersey.
© 2023 AmeriHealth Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer